Polly Matzinger's “danger model” finds its predicted danger-denoting self moieties

Bretscher, 1970, A theory of self-nonself discrimination, Science, 169, 1042, 10.1126/science.169.3950.1042 Cohn, 1996, The two-signal model and ‘self’-reactivity: are they really compatible? A reply to Faro & Carneiro, Scand J Immunol, 43, 1, 10.1046/j.1365-3083.1996.d01-17.x-i2 Mescher, 2006, Signals required for programming effector and memory development by CD8+ T cells, Immunol Rev, 211, 81, 10.1111/j.0105-2896.2006.00382.x Steinman, 1978, Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice, Proc Natl Acad Sci USA, 75, 5132, 10.1073/pnas.75.10.5132 Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Jenkins, 1987, Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo, J Exp Med, 165, 302, 10.1084/jem.165.2.302 Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359 Steinman, 2003, Dendritic cell function in vivo during the steady state: A role in peripheral tolerance, Ann N Y Acad Sci, 987, 15, 10.1111/j.1749-6632.2003.tb06029.x Granucci, 2008, Central role of dendritic cells in the regulation and deregulation of immune responses, Cell Mol Life Sci, 65, 1683, 10.1007/s00018-008-8009-2 Kapsenberg, 2003, Dendritic-cell control of pathogen-driven T-cell polarization, Nat Rev Immunol, 3, 984, 10.1038/nri1246 Matzinger, 1994, Tolerance, danger, and the extended family, Annu Rev Immunol, 12, 991, 10.1146/annurev.iy.12.040194.005015 Matzinger, 2001, Essay 1: The Danger model in its historical context, Scand J Immunol, 54, 4, 10.1046/j.1365-3083.2001.00974.x Matzinger, 2002, The danger model: A renewed sense of self, Science, 296, 301, 10.1126/science.1071059 Matzinger, 2002, An innate sense of danger, Ann N Y Acad Sci, 961, 341, 10.1111/j.1749-6632.2002.tb03118.x Medzhitov, 2002, Decoding the patterns of self and nonself by the innate immune system, Science, 296, 298, 10.1126/science.1068883 Kawai, 2005, Pathogen recognition with Toll-like receptors, Curr Opin Immunol, 17, 338, 10.1016/j.coi.2005.02.007 Takeuchi, 2008, MDA5/RIG-I and virus recognition, Curr Opin Immunol, 20, 17, 10.1016/j.coi.2008.01.002 Akira, 2006, Pathogen recognition and innate immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015 Kawai, 2006, Innate immune recognition of viral infection, Nat Immunol, 7, 131, 10.1038/ni1303 Ridge, 1998, A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell, Nature, 393, 474, 10.1038/30989 Schoenberger, 1998, T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions, Nature, 393, 480, 10.1038/31002 Lanzavecchia, 1998, Immunology. Licence to kill, Nature, 393, 413, 10.1038/30845 Martin-Fontecha, 2008, CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming, J Exp Med, 205, 2561, 10.1084/jem.20081212 Seong, 2004, Hydrophobicity: An ancient damageassociated molecular pattern that initiates innate immune responses, Nat Rev Immunol, 4, 469, 10.1038/nri1372 Liberek, 2008, Chaperones in control of protein disaggregation, EMBO J, 27, 328, 10.1038/sj.emboj.7601970 Javid, 2007, Structure and function: Heat shock proteins and adaptive immunity, J Immunol, 179, 2035, 10.4049/jimmunol.179.4.2035 Callahan, 2008, Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation, Proc Natl Acad Sci USA, 105, 1662, 10.1073/pnas.0711365105 Srivastava, 2005, Immunotherapy for human cancer using heat shock protein-peptide complexes, Curr Oncol Rep, 7, 104, 10.1007/s11912-005-0035-8 Binder, 2007, Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins, J Immunol, 179, 7254, 10.4049/jimmunol.179.11.7254 Binder, 2004, Essential role of CD91 in re-presentation of gp96-chaperoned peptides, Proc Natl Acad Sci USA, 101, 6128, 10.1073/pnas.0308180101 Vabulas, 2002, HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway, J Biol Chem, 277, 15107, 10.1074/jbc.M111204200 Binder, 2004, The heat-shock protein receptors: Some answers and more questions, Tissue Antigens, 64, 442, 10.1111/j.1399-0039.2004.00299.x Bromley, 2008, Orchestrating the orchestrators: Chemokines in control of T cell traffic, Nat Immunol, 9, 970, 10.1038/ni.f.213 Okamura, 2001, The extra domain A of fibronectin activates Toll-like receptor, J Biol Chem, 276, 10229, 10.1074/jbc.M100099200 Lasarte, 2007, The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo, J Immunol, 178, 748, 10.4049/jimmunol.178.2.748 Rovere-Querini, 2004, HMGB1 is an endogenous immune adjuvant released by necrotic cells, EMBO Rep, 5, 825, 10.1038/sj.embor.7400205 Dumitriu, 2005, HMGB1: Guiding immunity from within, Trends Immunol, 26, 381, 10.1016/j.it.2005.04.009 Bianchi, 2007, High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity, Immunol Rev, 220, 35, 10.1111/j.1600-065X.2007.00574.x Apetoh, 2007, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat Med, 13, 1050, 10.1038/nm1622 Scaffidi, 2002, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, 418, 191, 10.1038/nature00858 Shi, 2003, Molecular identification of a danger signal that alerts the immune system to dying cells, Nature, 425, 516, 10.1038/nature01991 Gu, 2004, The danger within, N Engl J Med, 350, 2721, 10.1056/NEJM200406243502622 Hu, 2004, Uric acid promotes tumor immune rejection, Cancer Res, 64, 5059, 10.1158/0008-5472.CAN-04-1586 Behrens, 2008, The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity, Blood, 111, 1472, 10.1182/blood-2007-10-117184 Kool, 2008, Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells, J Exp Med, 205, 869, 10.1084/jem.20071087 Rubic, 2008, Triggering the succinate receptor GPR91 on dendritic cells enhances immunity, Nat Immunol, 9, 1261, 10.1038/ni.1657 Kariko, 2004, mRNA is an endogenous ligand for Toll-like receptor 3, J Biol Chem, 279, 12542, 10.1074/jbc.M310175200 Cavassani, 2008, TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events, J Exp Med, 205, 2609, 10.1084/jem.20081370 Christensen, 2006, Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus, Immunity, 25, 417, 10.1016/j.immuni.2006.07.013 Barrat, 2005, Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus, J Exp Med, 202, 1131, 10.1084/jem.20050914 Leadbetter, 2002, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors, Nature, 416, 603, 10.1038/416603a Wartha, 2008, ETosis: A novel cell death pathway, Sci Signal, 1, pe25, 10.1126/stke.121pe25 Piccini, 2008, ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1‚ and IL-18 secretion in an autocrine way, Proc Natl Acad Sci USA, 105, 8067, 10.1073/pnas.0709684105 Mariathasan, 2006, Cryopyrin activates the inflammasome in response to toxins and ATP, Nature, 440, 228, 10.1038/nature04515 Pestka, 2007, The interferons: 50 years after their discovery, there is much more to learn, J Biol Chem, 282, 20047, 10.1074/jbc.R700004200 Gallucci, 1999, Natural adjuvants: Endogenous activators of dendritic cells, Nat Med, 5, 1249, 10.1038/15200 Bracci, 2008, Type I interferons as vaccine adjuvants against infectious diseases and cancer, Expert Rev Vaccines, 7, 373, 10.1586/14760584.7.3.373 Gasser, 2006, The DNA damage response arouses the immune system, Cancer Res, 66, 3959, 10.1158/0008-5472.CAN-05-4603 Raulet, 2003, Roles of the NKG2D immunoreceptor and its ligands, Nat Rev Immunol, 3, 781, 10.1038/nri1199 Diefenbach, 2002, The innate immune response to tumors and its role in the induction of T-cell immunity, Immunol Rev, 188, 9, 10.1034/j.1600-065X.2002.18802.x Guerra, 2008, NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy, Immunity, 28, 571, 10.1016/j.immuni.2008.02.016 Arina, 2007, The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNα, Int J Cancer, 121, 1282, 10.1002/ijc.22795 Arina, 2007, Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer, Expert Opin Biol Ther, 7, 599, 10.1517/14712598.7.5.599 Zitvogel, 2002, Dendritic and natural killer cells cooperate in the control/switch of innate immunity, J Exp Med, 195, F9, 10.1084/jem.20012040